COMP <GO>
KYMR vs PCVX // EV/EBITDA & P/E VALUATION
Kymera Therapeutics Inc. (NASDAQ) VS. Vaxcyte Inc. (NASDAQ) • 15-METRIC TALLY: KYMR 6
— PCVX 4
■ METRIC PARITY
LAST: $126.63 (+3.29%) • MKT CAP: $10.19B
valuation
—
LAST: $62.03 (-0.93%) • MKT CAP: $9.85B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KYMR VS. PCVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KYMR | PCVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.40% | -27.60% | +6.20 | KYMR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.30% | -6.79% | +4.49 | KYMR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -33.50% | -26.50 | PCVX | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 0.00% | +68.00 | KYMR | /net-margins <GO> |
| Revenue Growth (YoY) | -16.70% | 19.80% | -36.50 | PCVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 18.11 | +7.89 | KYMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.6 | 50.1 | +11.50 | KYMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 1.07 | -0.12 | PCVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.4x | 23.0x | +7.40 | PCVX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.19B | $9.85B | $340.1M | KYMR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KYMR REV | PCVX REV | KYMR GROSS % | PCVX GROSS % | KYMR FCF | PCVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $39.2M | $0 | 0.0% | — | -$234.3M | -$669.3M |
| FY 2024 | $47.1M | $0 | 0.0% | — | -$207.3M | -$475.1M |
| FY 2023 | $78.6M | $0 | — | — | -$106.4M | -$296.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KYMR // BETA 0.95
PCVX // BETA 1.07